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SUMMARY
Iron dysregulation has been linked to a variety of human diseases, such as anemia,
Friedreich’s ataxia, X-linked sideroblastic anemia, sideroblastic-like microcytic anemia,
and myopathy. Thus, it is vitally important to understand the mechanisms for regulating
intracellular iron. Here, we use fluorescence microscopy techniques in live cells to study
interactions of the yeast proteins Grx3/4, Aft1/2, and Bol2, which have been shown to be
involved in turning off iron import when the cell has adequate iron. Modified versions of
genes encoding these proteins have been incorporated into several yeast backgrounds to
use fluorescence to monitor interactions under varying iron levels.
ABSTRACT
Iron metabolism disorders are the most common nutritional disorders in the
world. Because iron is integral in many cellular processes, such as oxygen transport in
blood and energy production in mitochondria, it is vital that adequate iron levels are
maintained in the body. As a result, understanding the mechanism of iron regulation is
critical to preventing and treating iron metabolism disorders. To better characterize iron
regulation at the cellular and molecular level, we use Saccharomyces cerevisiae, or
bakers’ yeast, as a model system. In S. cerevisiae, expression of iron uptake and import
genes is promoted by the paralogous transcription factors Aft1 and Aft2 which shuttle
between the nucleus and cytosol in an iron-dependent mechanism. It is hypothesized that,
in iron replete conditions, the monothiol glutaredoxins Grx3 and Grx4, and the BolA-like
protein Bol2 interact to form a [2Fe-2S] cluster bound heterodimer. This complex is
proposed to transfer a [2Fe-2S] cluster to Aft1/2 promoting their dimerization and
translocation into the cytosol, thereby turning off expression of iron uptake and storage
systems. Grx3/4 have been shown to interact with Aft1/2 in vivo, but no definite role has
been shown for Bol2 in this interaction. To investigate whether Bol2 is required for the
interaction between Aft1/2 and Grx3/4, each protein is fused with either the C-terminal
half (VC) or the N-terminal half (VN) of the yellow fluorescence protein Venus.
Bimolecular fluorescence complementation (BiFC) studies will be performed to
determine whether Grx3/4 interact with Aft1/2 in the absence and presence of Bol2.
Interactions will be monitored in cells grown under varying iron concentrations via
fluorescence microscopy and flow cytometry. We have successfully cloned the genes for
VN-tagged versions of Grx3 (VN-Grx3) and VC-tagged Aft1/2 (Aft1-myc-VC and mycAft2-VC) into vectors that allow for doxycycline-controlled (TetOFF) expression and
transformed them into various S. cerevisiae strains. Furthermore, we have confirmed the
expression of VN-Grx3 with western blot, and the expression of Aft1/2-VC via growth
rescue on plates. Since both Grx3/4 and Bol2 have close human homologs, these studies
will shed light on their interaction and functional roles in human iron metabolism.
INTRODUCTION

However, in excess iron conditions, the
same properties that make it so vital can
lead to the production of reactive oxygen
species (ROS) that damage nucleic acids,
proteins, and lipids in the cell and can lead
to organ damage in humans as a result of
oxidative stress.1 For that reason, cell

Iron is an essential micronutrient
that plays a vital role as a redox cofactor in
many cellular processes such as
respiration, translation, DNA replication
and repair, and oxygen transport.
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conditions.13,14
The
monothiol
glutaredoxins Grx3 and Grx4 have been
shown to influence Aft1/2 activity in iron
homeostasis. Deletion of GRX3 or GRX4
shows no phenotype but the double
deletion causes iron overaccumulation
from continuous activation of the iron
regulon. They are therefore believed to be
redundant and involved in removing
Aft1/2 from the DNA.15-17
Investigation of this Grx3/4-Aft1/2
relationship led to identification of the
BolA-like protein Bol2 (previously Fra2)
as part of an iron signaling complex that
sends an inhibitory signal to Aft1/2 under
iron
replete
conditions.18
As
a
consequence, Aft1/2 are proposed to
dimerize and be exported from the nucleus
to the cytosol via the exportin Msn5.18,19
Restriction of Grx4 to the cytosol did not
show an effect on Aft1/2 inhibition, so it is
believed that the Grx3/4-Bol2 complex
operates in the cytosol.18 Our group
previously demonstrated that Grx3 and
Bol2 form a [2Fe-2S]-bridged heterodimer
that transfers a [2Fe-2S] cluster to Aft2,
which drives Aft2 dimerization and
decreases its affinity for DNA. Although
Bol2 has been demonstrated to be required
for this interaction in vitro,20 the same has
not been shown in vivo. Bimolecular
fluorescence complementation studies are
a promising way to test this hypothesis.
These studies involve tagging of
two interacting proteins each with one half
the yellow fluorescence protein (YFP)
known as Venus. If the proteins interact,
the two halves will come together to
reform the complete fluorescent protein
and generate a fluorescent signal
detectable by microscopy or flow
cytometry.21 To reduce the chance that the
interaction between the target proteins
hinders interaction between the two
fluorescent protein halves, a flexible linker
sequence is built between the target

survival depends on maintaining optimal
iron levels via complex mechanisms
including
balanced
intracellular
distribution
between
cellular
compartments and strict control of iron
uptake. Loss of this control, leading to
abnormally high or low levels of
intracellular iron, can cause either iron
overload or iron deficiency. Iron
dysregulation has been linked with human
diseases such as anemia, which is the most
common nutritional disorder in the world2,
Friedreich’s ataxia, X-linked sideroblastic
anemia, sideroblastic-like microcytic
anemia, and myopathy.3,4 Due to these
health concerns, understanding the
mechanisms
for
maintaining
iron
homeostasis is an important field of
current research.
Brewer’s yeast, Saccharomyces
cerevisiae, is a common model organism
for studying iron regulation and transport
due to its ease of genetic manipulation and
the evolutionary conservation of pathways
for iron uptake, distribution, and iron
cofactor
biosynthesis.5,6
Mechanistic
insight provided by yeast studies has led to
greater understanding of human diseases,
including iron-related diseases such as
Friedreich’s
ataxia
and
7-9
aceruloplaminemia.
Yeast iron import
and uptake is regulated in the nucleus by
the paralogous transcription factors Aft1
and Aft2, which activate several genes
involved in iron uptake, transport, and
storage (known as the iron regulon) under
iron deplete conditions. However, under
iron replete conditions, Aft1/2 are found as
dimers in the cytosol indicating that the
transcription factors are exported from the
nucleus when adequate iron is present in
the cell.10-12 Although Aft1/2 are paralogs,
Aft1
is
considered
the
primary
transcription factor because aft1∆ strains
show a more severe growth phenotype
than aft2Δ strains in iron-deficient
4

protein and the YFP fragment to enable
correct folding of each. Our research goal
is to use bimolecular fluorescence
complementation studies to test whether
Bol2 in required for the Grx3/4 interaction
with Aft1/2 in vivo. Furthermore, we are
attempting to determine in which cellular
compartment the interaction takes place
using fluorescence microscopy of live
cells expressing the BiFC fusion proteins.

tagged at the N-terminus with the N-YFP
half of Venus (VN) was cloned into the
pRS415 yeast overexpression vector,
creating pRS415-VN-linker-Grx3(Δ1-35)LEU2 or pWR101. In this construct, Grx3
protein expression was under the control
of the native GRX3 promoter and started
from the second start codon. The LEU2
gene was used to select for the yeast cells
transformed with the pWR101 plasmid.
However, VN-linker-Grx3 expression was
very low, almost nonexistent, as visualized
by western blotting because the native
promoter seems to require the sequence
between the first and second start codons
(Caryn Outten lab, unpublished data). A
new plasmid, pRS415-VN-linker-Grx3LEU2 or pWR102, containing VN-tagged
full length Grx3 in the pRS415 vector and
expressed under the native promoter was
then created. However, there was little to
no improvement in the VN-linker-Grx3
expression when the plasmid was
transformed into yeast cells. To
improve the expression levels of VNlinker-Grx3, the native GRX3 promoter in
pWR102 was replaced with the
constitutive PGK1 promoter and the new
plasmid
was
named
pRS415PGK1promoter-VN-linker-Grx3(Δ1-35)LEU2, or pAA120. Finally, VN-linkerGrx3 was cloned into the pCM189 yeast
overexpression vector containing the
TetOFF doxycycline-repressible promoter,
the new plasmid was named pCM189TetOFF-VN-linker-Grx3-URA3,
or
pWR103.
Aft2 was tagged at the N-terminus
with one myc tag for immunoblot
detection purposes and with the VC tag at
the C-terminus. The tagged gene was then
inserted into the pCM189-TetOFF-LEU2
backbone vector and the resulting plasmid
was called pCM189-TetOFF-myc-Aft2linker-VC-LEU2, or pWR105.

METHODS
All chemicals were purchased from
Sigma, ThermoFisher, or otherwise
specified and were of reagent grade.
Plasmid Production
Initially, AFT1-VC was integrated
into the S. cerevisiae genome, and
although PCR colony screening indicated
the presence of AFT1-VC in place of the
native AFT1 gene, Aft1-VC expression
was not detectable using western blotting
when probed with the YFP antibody.
Consequently,
the
pCM189
yeast
overexpression vector containing the
TetOFF inducible promoter was used to
clone Aft1 tagged with both a myc tag and
the C-terminal half of Venus (VC) tag at
the C-terminus of Aft1. The resulting
plasmid was named pCM189-TetOFFAft1-myc-linker-VC-LEU2 or pWR104.
The LEU2 gene was used for selecting
transformed cells when incorporated into
yeast strains (see “Yeast Transformation”
section). The TetOFF promoter is an
overexpression promoter that can be
turned off by the addition of doxycycline
(doxy) and was used as a tool for
controlling the protein expression.
Attempts to integrate VN-GRX3
into the S. cerevisiae genome were
unsuccessful. Therefore, a gene encoding
Grx3 missing the first 35 amino acids and
5

Table 1: Example PCR for amplification of inserts used in plasmid production
5 ng/μL DNA Template
1 μL
2 μL
4 μL
5x Q5 Buffer
10 μL
10 μL
10 μL
10 mM dNTPs
1 μL
1 μL
1 μL
5 μM FW Primer
5 μL
5 μL
5 μL
5 μM REV Primer
5 μL
5 μL
5 μL
Q5 Enhancera
10 μL
10 μL
10 μL
Q5 Polymerase (2000
0.5 μL
0.5 μL
0.5 μL
U/mL)
Sterile ddH2O
to 50 μL
to 50 μL
to 50 μL
a
Q5 Enhancer was only used for linker-VC and myc-Aft2 fragment amplifications because of their high
G/C contents (≥65%).
Table 2: PCR Primers used for amplification of inserts used in plasmid production
Fragment
Primer Names
Primer Sequence (5’ to 3’)a,b
cggatcaattcgggggatccTATAAAACCAT
VN-Grx3-Fw
GGTGAGCAAGG
VN-Grx3
ctgcagggccctagcggccgcTGGCGCGCCT
VN-Grx3-Rev
TAAGATTG
actaaattaccggatcaattcgggggatccATGGA
FW1-Aft1-myc-VC
AGGCTTCAATCCG
Aft1-myc
ggattttgcacgccggCTCGAGGTCTTCTT
pWR104-REV1
CGGAAATC
agaagacctcgagCCGGCGTGCAAAATC
pWR104-FW2
CCG
Linker-VC
(Aft1)
tgcggccctcctgcagggccctagcggccgcTTAC
pWR104-REV2
TTGTACAGCTCGTCCATGC
actaaattaccggatcaattcgggggatccatggaaca
FW1-pWR105
gaagttgatttccgaagaagacctcgagATGAAA
GCAAAGTCGATG
myc-Aft2
tgcacgccggacgATATTTTGATATTAA
REV1-pWR105
GGCTGGG
aatatcaaaatatCGTCCGGCGTGCAAAA
FW2-pWR105
TC
Linker-VC
(Aft2)
tgcggccctcctgcagggccctagcggccgcTTAC
REV2-pWR105
TTGTACAGCTCGTCCATG
a
Restriction enzyme sequence included in the primer is shown in bold.
b
The myc tag in the myc-Aft2 PCR forward primer is shown underlined.

The pWR103, pWR104 and
pWR105 plasmids were then transformed
into yeast strains for subsequent use in
BiFC studies. The detailed method for
creating these plasmids is described
below.
Production of pWR103, pWR104,
and pWR105 began with amplifying each
target gene or tag from other plasmids (see
below) using polymerase chain reaction
(PCR) such as the reaction seen in Table 1
and the primers listed in Table 2. The VNlinker-Grx3 fragment required for
pWR103 was amplified out of pAA120.

Restriction Enzyme
BamHI
NotI
BamHI
NotI
BamHI
NotI

The Aft1-myc and linker-VC fragments
for pWR104 were amplified from pESCAft1-myc (created in 2016 by summer
high school student Wesley Leaphart in
the Outten Lab and pCM189-TetOFFFra2-VC18 (gift from Prof. Dennis Winge),
respectively. The myc-Aft2 and linker-VC
fragments for pWR105 were amplified
from S. cerevisiae genomic DNA and the
pCM189-TetOFF-Fra2-VC
plasmid,
respectively. In the myc-Aft2 PCR, the
myc tag was built into the forward primer
allowing Aft2 amplification from genomic
6

Table 3: Gibson Assembly experimental set up
Plasmid
Ratio
pWR103

100 ng : 200 ng

Incubation Time (min)
30
60
17
30
45
60

a

100 ng : 200 ng : 200 ngb
pWR104

50 ng : 100 ng : 100 ngb
0.05 pmol : 0.1 pmol: 0.1 pmolb
15
0.02 pmol : 0.1 pmol : 0.1 pmolb
50 ng : 100 ng : 100 ngc
100 ng : 200 ng : 200 ngc
15
pWR105
0.05 pmol : 0.1 pmol : 0.25pmolc
0.05 pmol : 0.1 pmol : 0.1 pmolc
Table indicates ratios and incubation times used in separate GA reactions. For example, the pWR103
reaction was carried out for the given ratio in two separate reactions with the specified times. Reactions
under bolded conditions produced the successful GAs that were used in the next experimental steps.
a
vector : VN-linker-Grx3
b
vector : Aft1-myc : linker-VC
c
vector : myc-Aft2 : linker-VC

DNA with the myc tag inserted at the Nterminus (Table 2).
These fragments were inserted into
the plasmid backbones pCM189-TetOFFGrx4-VN for pWR103 and pCM189TetOFF-Fra2-VC18 for pWR104/pWR105.
Both backbones were digested with
BamHI and NotI to provide an open site
for the fragments to insert during plasmid
creation via Gibson Assembly (GA).22 For
the GA reactions, each fragment and the
backbone vector were mixed in solution
with a GA master mix of enzymes (New
England Biolabs) which assembled the
final plasmid by combining the
fragments/inserts and vector backbone
during incubation at 50 °C. The GA
vector:fragment/insert
ratios
and
incubation times used during plasmid
assembly are listed in Table 3.

backbone vectors and inserts were diluted
to similar concentration as used in the GA
reactions and loaded into the agarose gels
as controls. The GA plasmids deemed
potentially correct, based on the gel, were
transformed into Escherichia coli DH5α
chemically competent cells using a
standard transformation protocol. The
transformations were done in duplicate for
each strain using 1 μL and 2 μL of the GA
products. The transformed cells, along
with a non-transformed control of DH5α,
were then incubated overnight (16-18
hours) on LB + 100 μg/mL Amp plates at
37 °C. The amplified GA plasmid was
then isolated using the Wizard® Plus
Minipreps DNA Purification System
(Promega) for the pWR103 plasmid and
the ThermoScientific GeneJet Plasmid
Miniprep kit for the pWR104 and
pWR105 plasmids. The purified plasmids
were subjected to restriction digestions to
verify that the plasmids produced were the
intended product. pWR103 was digested
with HindIII and EcoRI-HF. pWR104 was
digested with NdeI and HindIII. pWR105
was digested with EcoRI-HF and NheI-

Plasmid Amplification and Verification
The GA reaction mixtures were
mixed with 1x EZ Vision One DNA
Loading Dye (Amresco), ran on 0.8%
agarose gels and visualized using Gel
DocTM EZ Imager (BIO-RAD). Digested
7

Table 4: Primers used for plasmid confirmation by DNA sequencing (Genewiz)
Plasmid
Primer name
Primer Sequence (5’ to 3’)
FW
pCM189_G4VN_FW
GGGATGCATGTGCTCTGTATG
FW
1_Grx3_VN/VC_scrn
CAGTTGGGCAGAACCATGCAAAG
pWR103
REV 2_VN_screen
GTGGTGCAGATCAGCTTCAG
REV M13R
Genewiz primer
FW
pCM189_G4VN_FW
GGGATGCATGTGCTCTGTATG
FW
1_Aft1_VN/VC_scrn
CCAGTCCATCATGACCCAAATG
pWR104
REV 2_VC_screen
GTGGTGCAGATCAGCTTCAG
REV M13R
Genewiz primer
FW
pCM189_G4VN_FW
GGGATGCATGTGCTCTGTATG
REV 2_VC_screen
GTGGTGCAGATCAGCTTCAG
pWR105
REV M13R
Genewiz primer

HF. Samples that yielded the correct
digestion pattern were confirmed by DNA
sequencing (Genewiz) using the primers
described
(Table
4).
pWR103/pWR104/pWR105
plasmids
confirmed by DNA sequencing were then
inserted in yeast strains via chemical
transformations (see below).

(EDTA) + 100 mM Tris (10x TE
solution), and 100 μL lithium acetate
(LiAc) at pH 7.4. 10 mg/mL sonicated
salmon sperm DNA was boiled for 10
minutes at 98 °C.
Transformations were prepared
using 100 μL of the resuspended yeast
cells, 10 μL boiled salmon sperm DNA,
and either 5 μL of DNA or sterile,
ultrapure H2O as a control. 500 μL of a
36% poly(ethylene glycol) (PEG, MW
3350), 100 mM LiAc, 1x TE solution was
added to each transformation and mixed
by inverting the microcentrifuge tube. The
cells were then incubated at 30 °C for one
hour. 5 μL DMSO was added to each and
they were moved to 42 °C for 10 minutes.
1 mL sterile, ultrapure H2O was added to
each and they were moved to ice for 2
minutes. Finally, the cells were spun down
at 12000 rpm for 30 seconds and the
supernatant was aspirated off. The cells
were resuspended in 100 μL sterile,
ultrapure H2O and plated on selective
media (2% bacteriological agar, US
Biological) for anaerobic growth at 30 °C
for 48-72 hours. The selective media used
for all steps involving pWR103 was
synthetic complete lacking uracil (SCURA). Selective medias for pWR104 and
pWR105 was synthetic complete lacking
leucine (SC-LEU). For transformations in
which both plasmids were inserted in the
yeast cells, the selective media was

Yeast Transformation
Deletion strains (grx3Δ, bol2Δ,
aft1Δ and aft2Δ) from the BY4741 (MATa
his3Δ1
leu2Δ0
met15Δ0
ura3Δ0)
background were derived from the
Saccharomyces Genome Deletion Project
and purchased from Open Biosystems.
Strains were plated on YPD plates and
incubated anaerobically at 30 °C for 48-72
hours. YPD liquid cultures (5-mL) were
inoculated with a loopful of cells from
each strain and grown for 4-5 hours at 30
°C with shaking. The pWR103 and
pWR104 plasmids were transformed into
grx3Δ, bol2Δ, and aft1∆ strains. pWR105
was transformed into grx3Δ and aft2Δ.
The 5-mL cultures were centrifuged at
3000 rpm for 5 minutes. The cells were
resuspended in sterile, ultrapure H2O,
transferred to a microcentrifuge tube, and
centrifuged at 14000 rpm for 10 seconds.
The supernatant was aspirated off and the
cells were resuspended in 800 μL sterile
ultrapure H2O, 100 μL of a pH 8 solution
of 10 mM ethylenediaminetetraacetic acid
8

Figure 1. Growth methods used in preparation for Western blotting. A) The initial method of
growing cells for western blot, which involved three steps of incubating selective media cultures 24
hours at 30 °C while shaking. In the first step, a 5-mL selective media culture without doxy was
inoculated with cells from a plate. After the first culture was incubated, the second selective media
culture with 1 μg/mL doxy was inoculated with cells from the first at a 1000x dilution. After the second
culture was incubated, the final 50-mL culture without doxy was inoculated with cells from the
previous culture at a 50x dilution and incubated. B) The second method of growing cells for western
blot, which involved two steps of incubating selective media cultures 24 hours at 30 °C while shaking.
The initial 5-mL selective media culture with 1 μg/mL doxy was inoculated from plates, like the first
growth method. After that culture grew, two 1000x dilutions were prepared in 50-mL cultures, one with
and one without 1 μg/mL doxy. This growth method was designed so proteins from non-induced and
induced cultures can be loaded side by side to better visualize the expression of desired products.

synthetic complete lacking both uracil and
leucine (SC-LEU-URA).

Western blotting: Initially, proteins
were prepared for western blot following a
protocol described in previous work.19 The
cells from the glycerol stocks were plated
on selection media, grown anaerobically
for 48-72 hours at 30 °C, and then
inoculated in 5-mL selective media
cultures for 24 hours at 30 °C. These
cultures were grown overnight, diluted
1000x into fresh 5-mL selective media
cultures supplemented with 1 μg/mL doxy,
and grown for an additional 24 hours at 30
°C. Fresh 50-mL selective media cultures
were inoculated with the second overnight
cultures to a 50x dilution and grown 24
hours at 30 °C prior to lysing the cells and

Yeast Transformation Confirmation
The transformations were tested
via repetitive selection, western blotting
and/or spot tests (see below).
Repetitive
selection:
The
transformations were repeatedly grown
anaerobically at 30 °C for 48-72 hours on
corresponding 2% agar selective media to
ensure that only cells containing the
desired plasmid survive. Cell stocks of the
transformed cells were prepared in
selective media with 12-15% glycerol and
stored at -80 °C.
9

extracting the proteins (Figure 1A).18
Unfortunately, our tagged proteins were
not detected on western blots. For this
reason, another growth method in which
cells were grown in 5-mL selection
cultures supplemented with 1 μg/mL doxy
for 24 hours at 30 °C before being
inoculated into two 50-mL selection
cultures (1000x dilutions) either with or
without 1 μg/mL doxy (Figure 1B).23
These cultures were then grown 24 hours
at 30 °C and a whole cell yeast extraction
with glass beads protocol was used to
isolate total protein from the cell cultures.
Because doxy inactivates TetOFF plasmid
expression, this growth method produced
cell lysates that contained our tagged
proteins when doxy was absent (induced
cells) and cell lysates that did not contain
the desired proteins when doxy was
present (non-induced cells).
Bradford Assay was used to
determine protein concentration for each

whole cell extraction. Using this
information, samples of 75 µg protein in
20 µl + 4 µl 6x Laemmli buffer
(www.easyprotocols.com/6x-laemmlibuffer-sample-buffer-for-western-blot)
were prepared for each transformation and
run on Tris-glycine SDS-PAGE gels
(Invitrogen by ThermoScientific). The
proteins were transferred to nitrocellulose
membranes (Amersham) as part of the
standard western blot procedure and the
membranes were incubated at room
temperature with equal amounts PBS and
Odyssey blocking buffer (LI-COR®)
overnight. The next day, the membranes
were incubated with the appropriate
primary antibody, washed 4 times with 20
mL PBS + 0.1% Tween (PBST), incubated
with the appropriate secondary antibody,
and washed 4 times with 20 mL PBST
before visualization with the Odyssey
Imaging System (LI-COR). Antibodies are
listed in Table 5.

Invitrogen
(A11122)

1:1,000

Goat α-rabbit

LI-COR
(926-32211)

1:12,500

α-Grx3

N/A

1:2,500

Goat α-rabbit

LI-COR
(926-32211)

1:12,500

α-c-Myc

Santa Cruz
Biotechnology
(9E10)

1:2,000

Goat α-mouse

LI-COR
(926-68070)

1:20,000

α-GFP

Invitrogen
(A11122)

1:1,000

Goat α-rabbit

LI-COR
(926-32211)

1:12,500

α-Grx3

N/A

1:2,500

Goat α-rabbit

LI-COR
(926-32211)

1:12,500

α-c-Myc

Santa Cruz
Biotechnology
(9E10)

1:2,000

Goat α-mouse

LI-COR
(926-68070)

1:20,000

α-GFP

Invitrogen
(A11122)

1:1,000

Goat α-rabbit

LI-COR
(926-32211)

1:12,500

α-Grx3

N/A

1:2,500

Goat α-rabbit

LI-COR
(926-32211)

1:12,500

VN-Grx3

α-GFP

Aft1-myc-linker-VC

Dilution
Factor

myc-Aft2-linker-VC

Table 5: Antibodies used for western blotting of transformations for each plasmid
Primary
Company (Cat#)
Dilution
Secondary
Company
Antibody
Factor
Antibody
(Cat#)
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transformed
cells
were
grown
anaerobically at 30 °C for 48-72 hours.
These cells were used to inoculate a 5-mL
culture of selective media + 100 μM iron
chelator
bathophenanthrolinedisulfonic
(BPS) + 5 μg/mL doxy for Aft1-myc-VC
and myc-Aft2-VC, which were grown
overnight at 30 °C with shaking. The cells
were serially diluted to prepare solutions
of OD 2.0, 0.2 and 0.02. 3 μL of each
dilution was plated (Figure 2) on various
selective media as described in Table 6.
These plates were then grown 48-144
hours depending on how sickly the cells
were under the given conditions.

Figure 2. Diagram of how spot testing dilutions
were plated on selective media. The plate was
split in half so two different sets of transformed
cells could be tested per plate. Each row on both
sides corresponds to a different colony for that set
of transformation cells. Each column corresponds
to the dilution plated at that position. OD 2.0, 0.2,
and 0.002 dilutions corresponds to the left,
middle, and right columns, respectively, on each
side of the plate.

RESULTS
Cloning of VN-linker-Grx3, Aft1-myclinker-VC, and myc-Aft2-linker-VC
Containing Plasmids
After each GA attempt, the
products were run on agarose gels to
visualize and evaluate whether they were
successful. For the VN-Grx3 gel, the size
difference between the expected GA
product (9647 bp) and the digested
pCM189-TetOFF-Grx4-VN
vector
backbone (9675 bp) was too small to see
the difference on the gel (Figure 3A).
However, the GA product for Aft1-myc-

Spot testing: Spot tests were used
for confirming the expression of pWR104
and pWR105 plasmids in yeast cells,
taking advantage of the reported limited
growth exhibited by the aft1∆ and aft2Δ
strains when grown under iron depleted
conditions.13,14 To prepare for spot testing,

Table 6: Growth media used for testing the expression of Aft1-myc-VC and myc-Aft2linker-VC in various strains via spot testing
Media
BPS
FAS
Doxy
100 μg/mL
100 μg/mL
2 μg/mL
Aft1-myc-linkerSC-LEU
VC
100 μg/mL
100 μg/mL
1 μg/mL
100 μg/mL
Aft1-myc100 μg/mL
2 μg/mL
linker-VC + VN- SC-LEU/-URA
100 μg/mL
linker-Grx3
100 μg/mL
1 μg/mL
1 μg/mL
100 μg/mL
Myc-Aft1SC-LEU
linker-VC
100 μg/mL
2 μg/mL
100 μg/mL
100 μg/mL
1 μg/mL
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Figure 3. Gel electrophoresis for preliminary assessment of the GA products. A) GA for pWR103.
DNA ladder (8 µg total DNA) was loaded in leftmost lane, followed by 5 µL GA mixture (9647 bp), 5
µL VN-linker-Grx3 PCR insert (1346 bp), and 5 µL pCM189 digested vector (9675 bp). The vector is a
similar size to the expected GA, so we cannot conclusively say whether the plasmid was produced
based on the agarose gel results. The lower band corresponds to leftover VN-Grx3 fragment that was
not incorporated into the vector backbone. B) GA for pWR104. 5 µL two GA mixtures (12424 bp)
using different pmol ratios were loaded into the leftmost lanes, followed by 5 µL pCM189 digested
vector (10681 bp), 5 µL Aft1-myc PCR insert (2152 bp), 5 µL linker-VC PCR insert (347 bp), and
DNA ladder (8 µg total DNA). There appears to be a band corresponding to pWR104 above another
corresponding to the digested vector. Beneath those bands, additional bands represent the leftover Aft1myc and linker-VC fragments that were not incorporated into the vector. C) GA for pWR105. 5 µL of
linker-VC PCR insert (322 bp) was loaded into the leftmost lane, followed by 5 µL GA mixture (11605
bp), 5 µL myc-Aft2 insert (1327 bp), and DNA ladder (8 µg total DNA). Beneath the band
corresponding to pWR105 are two bands corresponding to the myc-Aft2 and linker-VC PCR inserts.

VC (12424 bp) was much larger than the
digested
pCM189-TetOFF-Fra2-VC
vector (10681 bp), so two bands can be
seen (Figure 3B). The larger corresponds
to the GA product while the smaller
corresponds to leftover vector that the
Aft1-myc and linker-VC fragments were
not inserted into. There is also a faint
second band above the leftover Aft1-myc
insert in the GA lane which may represent
where the Aft1-myc and linker-VC
fragments were joined together but not
inserted into the vector. The GA product

and digested backbone vector were too
close in size for myc-Aft2-linker-VC as
well. However, the myc-Aft2 and linkerVC fragments loaded next to the GA were
identical quantities to the amounts loaded
from the GA, making it easy to assess the
amount of each consumed during the GA
reaction for the assembly of the pWR105
plasmid. Because the bands in the GA lane
were slightly less intense, some of the
PCR products loaded into the GA were
likely taken up by the vector to form the
myc-Aft2-linker-VC plasmid (Figure 3C).
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Figure 4. Restriction digest for testing colonies. 20 µl restriction digestion reactions were incubated
at 37 °C for 1 hour and loaded on a 0.8% agarose gel. A) pWR103 was digested with HindIII and
EcoRI-HF. Only colony 2 looks like the correct plasmid. Colonies 3 and 5 resemble the vector’s
digestion pattern. Colonies 1 and 4 look different from both. B) pWR104 was digested with NdeI and
HindIII. All colonies look like the expected plasmid except colony 4, which looks like the vector. C)
pWR105 was digested with EcoRI-HF and NheI-HF. Colonies 6 and 7 appear to be the correct plasmid.
The other colonies, including the colonies not shown, look like the vector. The red boxes identify the
colonies with the expected digestion pattern.

After the plasmids were amplified
in E. coli DH5α competent cells and
purified, restriction digests confirmed that
the plasmids extracted from the colonies
were the correct GA products (Figure 4).

The restriction enzymes were chosen to
produce patterns that differentiate between
the vector and intended products by
digesting at several locations, including
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Figure 5. Example of yeast transformation plates. This transformation is pWR104 in the bol2Δ,
grx3Δ, aft1Δ, and WT backgrounds (left to right) plated on SC-LEU selective media. The plates were
incubated anaerobically for 48 hours at 30 °C. Abundant growth on transformation plates (top row) and
no growth on the controls (bottom row) indicates the transformation was successful.

inside the fragments that were inserted
during the GA.
Agarose gel of the pWR103
plasmid digested with HindIII and EcoRIHF showed that only colony 2 contained
the expected digest pattern (Figure 4A).
Colonies 3 and 5 show the expected
digestion pattern for pCM189-TetOFFGrx4-linker-VN
backbone,
which
indicates that the PCR fragments were not
incorporated for these samples. Colonies 1
and 4 display unusual patterns that do not
match patterns of either the vector
backbone or the expected product. All
colonies from the pWR104 plasmid
digested with NdeI and HindIII appear to
show the pattern for the expected plasmid
except colony 4, which resembles the
pCM189-TetOFF-Fra2-linker-VC vector
digest (Figure 4B). Digests of the pWR105
plasmid show that colonies 6 and 7 are the
correct plasmid. The other colonies appear
to be the pCM189-TetOFF-Fra2-linkerVC backbone vector. DNA sequencing

(Genewiz) of each colony identified as
potentially correct verified these results.
Yeast Transformations and
Confirmation
Repetitive Growth: Colony 2 of the
VN-linker-Grx3 - containing plasmid,
colony 1 of the Aft1-myc-linker-VC containing plasmid, and colony 6 of the
myc-Aft2-linker-VC - containing plasmid
were transformed into the various yeast
strains required for these experiments (see
Methods). The transformations were tested
by repeated plating on selective media as
the plasmids contain genes that allow the
yeast to survive under those conditions
(Figure 5). Western blotting and spot tests
were also performed to verify the plasmids
were both present in the cells and the
tagged proteins were expressed.
Western
blotting:
The
transformation of pWR103 into grx3Δ was
determined to have failed as the western
blots probed with α-Grx3 showed no
expression for VN-linker-Grx3 but did
14

Figure 6. Western blot analysis for VN-linker-Grx3 and Aft1-myc-linker-VC expression in aft1Δ
and bol2Δ. A) VN-linker-Grx3 in aft1Δ and probed with α-Grx3. VN-linker-Grx3 expressed in all
colonies. Colony 2 appears to have the strongest expression. B) VN-linker-Grx3 in bol2Δ and probed
with α-Grx3. VN-linker-Grx3 expressed in all colonies. Colony 4 appears to have the strongest
expression. C) Aft1-myc-linker-VC in aft1Δ and probed with α-GFP. Aft1-myc-linker-VC was not
detected. D) Aft1-myc-linker-VC expressed in grx3Δ probed with α-GFP. Aft1-myc-linker-VC was not
detected.
Red boxes indicate the expected size of the modified proteins. Aft1-myc-linker-VC MW = 90.4 kDa;
VN-linker-Grx3 MW = 48.1 kDA. rxYFP (28 kDa) is a positive control for α-GFP. grx3Δ and Aft1myc are negative controls for α-Grx3 and α-GFP, respectively. n = non-induced (grown w/ doxy in
western prep). i = induced (grown w/o doxy in western prep). 1-4 denote the 4 individual colonies
screened. Red boxes indicate the expected size of the modified proteins.

The strong band in aft1Δ colony 2 and
bol2Δ colony 4 demonstrates that those
colonies produced the strongest expression
of VN-linker-Grx3. The strong band
located at 28.2 kDa corresponds to the
native Grx3, which is why the grx3∆
negative control lacks that band. The fact
that these bands are much stronger than
the VN-linker-Grx3 bands is concerning
because the TetOFF promoter should have

show a band for the Grx3-VC positive
control obtained from Dr. Angela Albetel
(results not shown). However, western
blots of pWR103 transformed into aft1∆
and bol2Δ probed with α-Grx3 show bands
with various intensities around 50 kDa that
are only present in the induced samples
and indicate expression of VN-linker-Grx3
protein (MW 48.1 kDa) for all colonies in
both aft1Δ and bol2Δ (Figure 6A and 6B).
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overexpressed
the
VN-linker-Grx3.
However, the colonies appear to express
VN-linker-Grx3 less than native Grx3
which could potentially interfere with our
experiments. It is also possible that α-Grx3
recognizes native Grx3 better than VNlinker-Grx3 which would also explain the
observed lower expression. Unfortunately,
the bol2Δ background displayed an
unexpected phenotype on nonfermentable
media (data not shown), which may result
from unknown spontaneous mutations,
making this strain untrustworthy for our
studies. As such, it must be recreated for
the experiments to proceed. In subsequent
transformations this background was not
used.
Western blotting with α-GFP on
the pWR104 transformations into aft1Δ
and grx3Δ indicate that neither
transformation could be confirmed by this
technique, or the protein was not being
expressed in either (Figure 6C and 6D).
No bands were seen at 90.4 kDa, the size
of Aft1-myc-linker-VC, for any colonies.
However, the rxYFP positive control
provided by Dr. Maxwell Darch was seen
in both western blots around 28 kDa,
confirming that the antibodies could
recognize the YFP protein. The Aft1-myc
- containing lysate from Debolina Hati
was used as a negative control since it
expresses Aft1 with no YFP fragments.
Although
Aft1-myc-linker-VC
could not be detected in the western blots,
the transformation plates grew extremely
well on selective media, which would be
unlikely if the plasmid is not present in the
cells. Because of these conflicting results,
the possibility that the antibodies were not
recognizing the proteins could not be
ignored and spot tests were employed as
an alternative method for testing the
expression of Aft1-myc-linker-VC (see
Spot Test Results section). Western blot of
Aft1-myc-linker-VC expression in aft1Δ +

pWR103 cells transformed with pWR104
plasmid and probed with α-c-Myc (Figure
7A) again failed to show the presence of
Aft1-myc-linker-VC. However, α-Grx3 on
the same gel showed the VN-linker-Grx3
bands in each induced colony (Figure 7B).
Similarly, western blot testing of VNlinker-Grx3 expression in aft1Δ +
pWR104 cells transformed with pWR103
also verified that VN-linker-Grx3 was
being expressed in all four induced
colonies (Figure 7C). For these colonies,
both α-GFP and α-c-Myc were used
together in hopes that at least one probe
will show Aft1-myc-linker-VC expression.
The VN-linker-Grx3 (48.1 kDa) bands
were located exactly where expected, but
the Aft1-myc-linker-VC could still not be
visualized by probing with either antibody
(Figure 7D). However, the Aft1-myc
positive control for α-c-Myc provided by
Debolina Hati was recognized by the α-cMyc antibody.
The same results were obtained for
western blotting of myc-Aft2-linker-VC in
aft2Δ with α-c-Myc (results not shown).
Again, the lack of a growth phenotype
during the selection for pWR105
transformed cells on SC-LEU plates
conflicted with these results, so a second
verification method was used (see below).
Spot Testing: aft1Δ and aft2Δ
strains have been shown to grow poorly
when grown in iron limited conditions.13,14
To test the expression of Aft1-myc-linkerVC and myc-Aft2-linker-VC in the aft1Δ,
aft2Δ, and grx3Δ strains, spot testing was
performed to see phenotypic differences in
growth on low iron media between parent
strains, and non-induced and induced
strains transformed with pWR104,
pWR105, or pWR103 and pWR104 cotransformed. Initially, cells transformed
with the Aft1-myc-linker-VC – containing
plasmid were plated and cultured in
selection media under normal iron
16

Figure 7. Western blot analysis for VN-linker-Grx3 and Aft1-myc-linker-VC co-expression in
aft1Δ. A) Aft1-myc-linker-VC in VN-linker-Grx3(aft1Δ) probed with α-c-Myc. Aft1-myc-linker-VC
was not detected. B) Aft1-myc-linker-VC in VN-linker-Grx3(aft1Δ) probed with α-Grx3. VN-linkerGrx3 expressed in all colonies. C) VN-linker-Grx3 in Aft1-myc-linker-VC(aft1Δ) probed with α-Grx3.
VN-linker-Grx3 expressed in all colonies. D) VN-linker-Grx3 in Aft1-myc-linker-VC(aft1Δ) probed
with α-c-Myc and α-GFP. Aft1-myc-linker-VC was not detected. VN-linker-Grx3 expressed in all
colonies.
Red boxes indicate the expected size of the modified proteins. Aft1-myc-linker-VC MW = 90.4 kDa;
VN-linker-Grx3 MW = 48.1 kDA; Aft1-myc (79.95 kDA) is a positive control for α-c-Myc and αGrx3. n = non-induced (grown w/ doxy in western prep). i = induced (grown w/o doxy in western prep).
1-4 denote the 4 individual colonies screened.

100 μM BPS in subsequent spot tests. In
this new growth method, Aft1-myc-linkerVC transformed cells were grown for 24
hours in 5 ml selection media
supplemented with 5 μg/ml doxycycline
and 100 μM BPS, then serial dilutions
were prepared and plated on selection
plates supplemented with either 100 μM
BPS or 100 μM FAS, and with or without
2 μg/ml doxycycline. Aft1-myc-linker-VC
in aft1Δ grew in low iron conditions only
when the plasmid was induced by the
absence of doxycycline and grew under

conditions, then serial dilutions were
transferred
to
SC-LEU
plates
supplemented with either 100 μM FAS for
the high iron condition or with 10 μM of
the iron chelator BPS for the low iron
condition. Using this method, no growth
limitations were observed, regardless of
iron availability (data not shown). The
cells may have accumulated enough iron
during the overnight growth to survive
growth on the iron depleted plates, and for
this reason both the beginning liquid
cultures and the plates were prepared with
17

Figure 8. Spot test results for the transformation and expression of Aft1-myc-VC in aft1Δ. Serial
dilutions of 4 individual colonies of Aft1-myc-VC in aft1Δ Batch 1 (from when western blotting
initially showed no protein expression) were plated on: A) SC-LEU with 100 µM BPS + 2 µg/mL doxy
(left) or just 100 µM BPS (right) and incubated aerobically at 30 °C for 5 days; B) SC-LEU with 100
µM FAS + 1 µg/mL doxy (left) or just 100 µM FAS (right) and incubated aerobically at 30 °C for 3
days. Serial dilutions of 4 individual colonies of Aft1-myc-VC in aft1Δ Batch 2 were plated on: C) SCLEU with 100µM BPS + 2 µg/mL doxy (left) or just 100 µM BPS (right) and incubated aerobically at
30 °C for 5 days; D) SC-LEU with 100 µM FAS + 1 µg/mL doxy (left) or just 100 µM FAS (right) and
incubated aerobically at 30 °C for 3 days. E) Serial dilutions of aft1Δ and grx3Δ background strains
grown for 3 days on SC as a positive control. F) Serial dilutions of aft1Δ and grx3Δ background strains
incubated for 5 days on SC-LEU as a negative control.
BPS=bathophenathrolinesulfonic acid; FAS=ferrous ammonium sulfate; doxy=doxycycline; 1-4
indicate that 4 individual colonies were screened.

high iron conditions regardless of whether
the plasmid was induced or not (Figure
8A-D). The aft1Δ and grx3Δ control
strains grown under the same conditions
and plated on synthetic complete (SC)
media supplemented with and without 2
μg/ml doxycycline and 100 μM BPS
exhibit the previously reported growth
phenotypes (Figure 8E).13-17 Additionally,
the aft1Δ and grx3Δ background strains

grown on SC-LEU media supplemented
with and without 2 μg/ml doxycycline and
100 μM BPS did not grow, reconfirming
that the presence of pWR104 plasmid
carrying the selection gene is required for
these cells to survive (Figure 8F).
Aft1-myc-linker-VC in grx3Δ
grew in low iron conditions only when the
plasmid was induced by the absence of
doxycycline and grew under high iron
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Figure 9. Spot test results for the transformation and expression of Aft1-myc-VC in grx3Δ. Serial
dilutions of 4 individual colonies of Aft1-myc-VC in grx3Δ Batch 1 (from when western blotting
initially showed no protein expression) were plated on: A) SC-LEU with 100 µM BPS + 2 µg/mL doxy
(left) or just 100µM BPS (right) and incubated aerobically at 30 °C for 5 days; B) SC-LEU with 100
µM FAS + 1 µg/mL doxy (left) or just 100 µM FAS (right) and incubated aerobically at 30 °C for 3
days. Serial dilutions of 4 individual colonies of Aft1-myc-VC in grx3Δ Batch 2 were plated on: C)
SC-LEU with 100 µM BPS + 2 µg/mL doxy (left) or just 100 µM BPS (right) and incubated aerobically
at 30 °C for 5 days: D) SC-LEU with 100 µM FAS + 1 µg/mL doxy (left) or just 100 µM FAS (right)
and incubated aerobically at 30 °C for 3 days.
BPS=bathophenathrolinesulfonic acid; FAS=ferrous ammonium sulfate; doxy=doxycycline; 1-4
indicate the 4 individual colonies screened. The controls from Figure 8 were used for these spot tests as
well.

conditions regardless of whether the
plasmid was induced or not (Figure 9AD). This result is somewhat unexpected
because Grx3 is supposed to be fully
redundant with Grx4,15-17 so growth
deficiency under low iron conditions was
not expected (see Figure 8E). Taken
together, these results indicate that Aft1myc-linker-VC is expressed in aft1Δ and
possibly grx3Δ backgrounds.
Spot tests of VN-linker-Grx3 cotransformed with Aft1-myc-linker-VC in
aft1Δ and grown as described above
(Figure 10) exhibited growth in SC-LEU/URA low iron conditions when the
plasmid is induced, indicating that the

Aft1-myc-linker-VC plasmid is also being
expressed (Figure 10A and 10B). Western
blot results confirmed expression of Grx3linker-VC previously (Figure 7B and 7C).
As expected, under high iron conditions,
the cells grew independent of plasmid
induction. Because the cells were able to
grow on SC-LEU/-URA media, both
plasmids must be expressed as they each
contain a gene that enables the production
of one of those amino acids. Additionally,
the tagged proteins are being produced
because the limited growth phenotype
expected for aft1Δ cells is recovered in
these transformations.
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Figure 10. Spot test results for the transformation and co-expression of Aft1-myc-linker-VC and
VN-linker-Grx3 in aft1Δ. Serial dilutions of 4 individual colonies of Aft1-myc-VC transformed into
VN-linker-Grx3(aft1Δ) cells were plated on: A) SC-LEU/-URA supplemented with 100 µM BPS + 2
µg/mL doxy (left) or just 100 µM BPS (right) and incubated aerobically at 30 °C for 5 days; B) SCLEU/-URA supplemented with 100 µM FAS + 1 µg/mL doxy (left) or just 100 µM FAS (right) and
incubated aerobically at 30 °C for 3 days. Serial dilutions of 4 individual colonies of VN-linker-Grx3
transformed into Aft1-myc-VC(aft1Δ) cells were plated on: C) SC-LEU/-URA supplemented with 100
µM BPS + 2 µg/mL doxy (left) or just 100 µM BPS (right) and incubated aerobically at 30 °C for 5
days; D) SC-LEU/-URA supplemented with 100 µM FAS + 1 µg/mL doxy (left) or just 100 µM FAS
(right) and incubated aerobically at 30 °C for 3 days.
BPS=bathophenathrolinesulfonic acid; FAS=ferrous ammonium sulfate; doxy=doxycycline; 1-4
indicate the 4 individual colonies screened. The controls from Figure 8 were used for these spot tests as
well.

Spotting of myc-Aft2-linker-VC containing plasmid transformed in aft2Δ
showed better growth on induced colonies
than non-induced colonies in low iron
conditions, indicating that the myc-Aft2linker-VC was expressed (Figure 11A).
The same cells showed no growth
impairment when grown on plates with
high iron and normal iron conditions, and
no significant difference was observed
between these two conditions (Figure 11B
and 11C). Although myc-Aft2-linker-VC
in grx3Δ grew well for the normal and
high iron conditions (Figures 11E and
11F), it appeared to grow better under low
iron conditions when the protein was not

expressed (Figure 11D). The nontransformed aft2Δ and grx3Δ control cells
grew well in all conditions on SC media,
though they took longer to grow in low
iron (Figure 11G), which was the expected
phenotype for aft2Δ. No growth was
observed for these control strains when
grown on SC-LEU, since they lack the
plasmid encoding the leucine production
gene (Figure 11H). Because the presence
and absence of doxy in the controls did not
affect their growth but appeared to affect
the growth of transformed cells, the spot
test for myc-Aft2-linker-VC in grx3Δ will
be repeated.
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Figure 11. Spot test results for the transformation and expression of myc-Aft2-linker-VC and
aft1Δ and grx3Δ. Serial dilutions of 4 individual colonies of myc-Aft2-linker-VC transformed into
aft2Δ cells were plated on: A) SC-LEU/-URA supplemented with 100 µM BPS and 2 µg/mL doxy (left)
or just 100 µM BPS (right), and incubated aerobically at 30 °C for 5 days; B) SC-LEU/-URA
supplemented with 1 µg/mL doxy (left) or just SC-LEU (right) and incubated aerobically at 30 °C for 2
days; C) SC-LEU/-URA supplemented with 100 µM FAS + 1 µg/mL doxy (left) or just 100 µM FAS
(right) and incubated aerobically at 30 °C for 2 days. Serial dilutions of 4 individual colonies of mycAft2-linker-VC transformed into grx3Δ cells were plated on: D) SC-LEU/-URA supplemented with 100
µM BPS + 2 µg/mL doxy (left) or just 100 µM BPS (right) and incubated aerobically at 30 °C for 5
days; E) SC-LEU/-URA supplemented with 1 µg/mL doxy (left) or just SC-LEU (right) and incubated
aerobically at 30 °C for 2 days; F) SC-LEU/-URA supplemented with 100 µM FAS + 1 µg/mL doxy
(left) or just 100 µM FAS (right) and incubated aerobically at 30 °C for 2 days. G) The aft2Δ and grx3Δ
background strains grown on SC with and without doxy and BPS or FAS for 3 days as a positive
control. H) The aft2Δ and grx3Δ background strains grown on SC-LEU with and without doxy and
BPS or FAS for 5 days as a negative control.
BPS=bathophenathrolinesulfonic acid; FAS=ferrous ammonium sulfate; doxy=doxycycline; 1-4
indicate the 4 individual colonies screened.

DISCUSSION

cerevisiae using BiFC studies. To
adequately accomplish our research goal,
Grx3/4 and Aft1/2 were tagged with either
the N-terminal half (VN) or C-terminal
half (VC) of the yellow fluorescence
protein Venus, respectively. A linker was

In this work, we present our efforts
to investigate whether Bol2 is required for
the interaction between Grx3/4 and Aft1/2
during in vivo iron regulation in yeast S.
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has been verified. Spot testing of mycAft2-VC in grx3Δ needs to be repeated as
the results were inconclusive. These
strains will be useful primarily in testing
the interaction between Grx3 and Aft1
through fluorescence microscopy.

Grx3/Aft1

Table 7: Summary of Experiments
Backgrounds
Plasmid
Required
grx3Δ
VN-Grx3
aft1Δ
bol2Δ
grx3Δ
Aft1-myc-VC
aft1Δ
bol2Δ
grx3Δ
VN-Grx3 and
aft1Δ
Aft1-myc-VC
bol2Δ
grx3Δ
VN-Grx3
aft2Δ
bol2Δ
grx3Δ
myc-Aft2-VC
aft2Δ
bol2Δ
grx3Δ
VN-Grx3 and
aft2Δ
myc-Aft2-VC
bol2Δ
grx4Δ
Grx4-VN
aft1Δ
bol2Δ
grx4Δ
Aft1-myc-VC
aft1Δ
bol2Δ
grx4Δ
Grx4-VN and
aft1Δ
Aft1-myc-VC
bol2Δ
grx4Δ
Grx4-VN
aft2Δ
bol2Δ
grx4Δ
myc-Aft2-VC
aft2Δ
bol2Δ
grx4Δ
Grx4-VN and
aft2Δ
myc-Aft2-VC
bol2Δ

Grx4/Aft2

Grx4/Aft1

Grx3/Aft2

Before experiments can proceed,
additional strains need to be created and
the bol2Δ background needs to be
recreated. To test Grx3 and Aft1
interaction, VN-linker-Grx3 (grx3Δ), VNlinker-Grx3 (bol2Δ), Aft1-myc-linker-VC
(bol2Δ), VN-linker-Grx3/Aft1-myc-linkerVC (grx3∆), and VN-linker-Grx3/Aft1myc-linker-VC (bol2Δ) still need to be
produced. Each of the plasmids has been
created, so the remaining steps are to redo
the transformation and verify if it was
successful using western blotting and spot
testing. Studying the interaction between
Grx3 and Aft2 will require cloning and
expression of VN-linker-Grx3 and mycAft1-linker-VC separately (for negative
controls) or together in grx3∆, aft2∆, and
bol2∆. Although only myc-Aft2-linker-VC
(aft2∆) has been successfully transformed,
both plasmids have been produced. The
co-transformations must be attempted and
verified. Then we will be ready to test the
interaction. Testing the Grx4-Aft1 and
Grx4-Aft2 interactions will require the
same set up in terms of the backgrounds
required with a native protein knockout for
each protein to be tested. Again, the
plasmids are created and only need to be
transformed into the background strains
and verified for the experiments to
commence. See Table 7 for a summary of
what yeast strains have been produced and
still need to be produced.
Once these yeast strains have been
produced, BiFC studies will be carried out
by monitoring the presence/absence of
fluorescence using an IX81 Automated
Inverted microscope (Olympus). Each

inserted between each protein and its
respective tag to allow for proper folding.
For each possible combination of tagged
proteins, a variety of yeast strains were
tested, including bol2∆, grx3∆, aft1∆, and
aft2∆ (Table 7). So far, VN-linker-Grx3 in
aft1∆,
Aft1-myc-linker-VC
in
grx3∆/aft1∆,
myc-Aft2-linker-VC
in
aft2Δ, and VN-linker-Grx3/Aft1-myclinker-VC in aft1Δ have been transformed
and the expression of the tagged proteins
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protein combination mentioned in Table 7
will be grown under varying iron
conditions (low, normal, high) and
visualized using the microscope. It is
expected that fluorescence from Grx3/4
interaction with Aft1/2 will be observed in
all backgrounds, other than bol2∆. This
would demonstrate that Bol2 is required
for the interaction between these two
protein types in vivo, thus confirming the
in vitro data.20 Additionally, we will be
able to visualize which cellular
compartment
the
Aft1/2-Grx3/4
interaction is taking place in to further
elucidate the mechanism by which the
interaction results in turning off iron
regulation genes.
Validating the S. cerevisiae iron
regulation model in which [2Fe-2S]Grx3/4-Bol2 complex interacts with
Aft1/2, leading to their dimerization and
subsequently inactivating the iron regulon,
would aid in understanding human
diseases and conditions. Glrx3 and BolA2,
the human homologs, may interact by a
similar mechanism, so understanding the
interaction and its function in a simpler
organism, like yeast, will contribute to our
understanding of how these two human
homologs function. This could lead to a
greater understanding of human iron
regulation and the roles of Glrx3 and
BolA2 in iron-related diseases.
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